Narrow-Band Imaging (NBI) Versus Lugol Chromoendoscopy in the Detection of Oesophagus Squamous Cell Carcinoma in High Risk Population
Completed
- Conditions
- FRENCH STUDY
- Interventions
- Diagnostic Test: UPPER ENDOSCOPY
- Registration Number
- NCT04224896
- Lead Sponsor
- Hôpital Edouard Herriot
- Brief Summary
Narrow-Band Imaging (NBI) is as sensitive as Lugol chromoendoscopy to detect oesophageal squamous cell carcinoma (SCC) and appears more specific than Lugol chromoendoscopy in expert centres but its specificity in current practice is not known. This study aimed to prove the superiority of NBI specificity over Lugol chromoendoscopy to detect oesophageal SCC and high-grade dysplasia (HGD) in current practice (including tertiary care centres, local hospitals and private clinics).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 335
Inclusion Criteria
- Patients had a history or current SCC
Exclusion Criteria
- NONE
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description NBI PATIENT UPPER ENDOSCOPY - LUGOL PATIENT UPPER ENDOSCOPY -
- Primary Outcome Measures
Name Time Method SPECIFICITY OF THE TWO DIAGNOSTIC STRATEGIES 4 years
- Secondary Outcome Measures
Name Time Method